212 related articles for article (PubMed ID: 31824653)
1. Recent advances in Merkel cell carcinoma.
Robinson CG; Tan D; Yu SS
F1000Res; 2019; 8():. PubMed ID: 31824653
[TBL] [Abstract][Full Text] [Related]
2. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
3. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
Bhatia S; Afanasiev O; Nghiem P
Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
[TBL] [Abstract][Full Text] [Related]
5. Update on Merkel Cell Carcinoma.
Harms PW
Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
[TBL] [Abstract][Full Text] [Related]
6. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
9. Association of Merkel Cell Polyomavirus Status With p53, RB1, and PD-L1 Expression and Patient Prognosis in Merkel Cell Carcinomas: Clinical, Morphologic, and Immunohistochemical Evaluation of 17 Cases.
Öğüt B; Bayram EK; İnan MA; Kestel S; Erdem Ö
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):371-378. PubMed ID: 37126387
[TBL] [Abstract][Full Text] [Related]
10. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
11. Merkel Cell Carcinoma Therapeutic Update.
Cassler NM; Merrill D; Bichakjian CK; Brownell I
Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell carcinoma update: the case for two tumours.
Nirenberg A; Steinman H; Dixon J; Dixon A
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1425-1431. PubMed ID: 31855292
[TBL] [Abstract][Full Text] [Related]
13. Avelumab and other recent advances in Merkel cell carcinoma.
Bommareddy PK; Kaufman HL
Future Oncol; 2017 Dec; 13(30):2771-2783. PubMed ID: 28976209
[TBL] [Abstract][Full Text] [Related]
14. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.
Becker JC; Stang A; Hausen AZ; Fischer N; DeCaprio JA; Tothill RW; Lyngaa R; Hansen UK; Ritter C; Nghiem P; Bichakjian CK; Ugurel S; Schrama D
Cancer Immunol Immunother; 2018 Mar; 67(3):341-351. PubMed ID: 29188306
[TBL] [Abstract][Full Text] [Related]
16. Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates.
Becker JC; Stang A; Schrama D; Ugurel S
Am J Clin Dermatol; 2024 Jul; 25(4):541-557. PubMed ID: 38649621
[TBL] [Abstract][Full Text] [Related]
17. Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.
Spada F; Bossi P; Caracò C; Sileni VC; Dei Tos AP; Fazio N; Grignani G; Maio M; Quaglino P; Queirolo P; Ascierto PA;
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35701070
[TBL] [Abstract][Full Text] [Related]
18. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma--pathogenesis, clinical aspects and treatment.
Schrama D; Becker JC
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1121-9. PubMed ID: 21923810
[TBL] [Abstract][Full Text] [Related]
20. Merkel cell carcinoma: recent insights and new treatment options.
Schrama D; Ugurel S; Becker JC
Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
